You are here

Article Text

Article menu
Congenital heart disease
Original research
O2 pulse slope correlates with stroke volume during exercise in patients with a Fontan circulation
  1. Karina Laohachai1,2,
  2. Rachael Cordina2,3,
  3. Yves D'Udekem4,
  4. Kathryn Rice5,
  5. Robert Weintraub6 and
  6. Julian Ayer2,7
  1. 1Cardiology, Women's and Children's Hospital Adelaide, North Adelaide, South Australia, Australia
  2. 2Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia
  3. 3Cardiology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
  4. 4Cardiac Surgery, Children's National Hospital, Washington, District of Columbia, USA
  5. 5Paediatric and Congenital Cardiac Services, Starship Children's Health, Auckland, New Zealand
  6. 6Cardiology, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia
  7. 7The Heart Centre for Children, Children's Hospital, Westmead, New South Wales, Australia
  1. Correspondence to Dr Karina Laohachai; karina.laohachai{at}sa.gov.au

Abstract

Background Peak oxygen pulse (O2pulse=oxygen consumption/heart rate) is calculated by the product of stroke volume (SV) and oxygen extraction. It has been shown to be reduced in patients with a Fontan circulation. However, in the Fontan population, it may be a poor marker of SV. We propose that the slope of the O2 pulse curve may be more reflective of SV during exercise.

Methods We analysed cardiopulmonary exercise test data in 22 subjects with a Fontan circulation (cohort A) and examined the association between peak SV during exercise (aortic flow measured on exercise cardiac MRI), and O2 pulse parameters (absolute O2 pulse and O2 pulse slopes up to anaerobic threshold (AT) and peak exercise). In a separate Fontan cohort (cohort B, n=131), associations between clinical characteristics and O2 pulse kinetics were examined.

Results In cohort A, peak aortic flow was moderately and significantly associated with O2pulseslopePEAK (r=0.47, p=0.02). However, neither absolute O2pulseAT nor O2pulsePEAK was significantly associated with peak aortic flow. In cohort B, O2pulseslopePEAK and O2pulseslopeAT were not significantly associated with clinical parameters, apart from a weak association with forced vital capacity.

Conclusion The slope of the O2 pulse curve to peak exercise may be more reflective of peak SV in the Fontan population than a single peak O2 pulse value.

  • Fontan Procedure
  • Heart Failure, Systolic
  • Heart Defects, Congenital

Data availability statement

All data relevant to the study are included in the article or uploaded as online supplemental information.

http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

https://doi.org/10.1136/openhrt-2023-002324

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    WHAT IS ALREADY KNOWN ON THIS TOPIC

    • Patients with a Fontan circulation have reduced peak oxygen pulse, a marker of stroke volume (SV) in the healthy population. However, with the potential of impaired oxygen extraction by exercising muscles, peak O2 pulse may be a poor marker for SV in this cohort.

    WHAT THIS STUDY ADDS

    • Peak O2 pulse slope may be more reflective of peak SV in the Fontan population than a single peak O2 pulse value.

    HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY

    • The O2 pulse slope may be a useful submaximal marker of SV in the Fontan cohort.

    Introduction

    Cardiopulmonary exercise testing (CPET) is an important tool in assessing the haemodynamic response to exercise in patients with a Fontan circulation, and certain CPET parameters are emerging as useful in the prognostic assessment of these patients.1 2 However, maximal exercise is not met in a substantial proportion of Fontan patients3 and hence there is significant interest in submaximal exercise parameters, their determinants and association with clinically relevant outcomes.4 5

    One maximal parameter, peak oxygen (O2) pulse, has been shown to be reduced in patients with a Fontan circulation.3 6 O2 pulse represents the relationship between oxygen consumption (VO2) and heart rate (HR) (O2 pulse=VO2/HR) and is determined by the product of stroke volume (SV) and oxygen extraction (arteriovenous oxygen difference (a-vO2)).7

    In healthy populations, the change in a-vO2 between rest and peak exercise is predictable, such that peak O2 pulse has been used as a non-invasive surrogate measure of SV.8 9 However, as SV plateaus from mid-range exercise onward,10 O2 pulse from mid-exercise is mainly determined by a-vO2. As skeletal muscle abnormalities are highly prevalent and variable in patients with a Fontan circulation,11 12 with the potential of impaired oxygen extraction by exercising muscles,13 peak O2 pulse may be a poor marker for SV in this cohort.14

    O2 pulse can be evaluated across the whole of exercise and O2 pulse kinetics, including the slope of the O2 pulse curve, have been examined in patients with a Fontan circulation.15 Fontan patients have been shown to have an altered O2 pulse slope compared with healthy controls. Given that O2 pulse slope takes into account both submaximal and maximal responses to exercise, we postulated that it, rather than peak O2 pulse, may be more strongly associated with SV.

    The relationship between SV during exercise and O2 pulse slope in Fontan patients has not been determined. Thus, the primary aim of this study in patients with a Fontan circulation was to examine the association between SV (assessed as ascending aortic flow measured by exercise cardiac MR (exCMR)) obtained during exercise, and peak O2 pulse and O2 pulse slope during CPET. As a secondary aim, we explored associations between clinical characteristics and both peak O2 pulse and O2 pulse slope in a larger cohort of patients with a Fontan circulation.

    Methods

    Recruitment

    Two cohorts of Fontan participants were used in this study as follows (figure 1):

    1. In the first cohort (cohort A—22 subjects with 40 CPETs and 26 exCMR analysed), we examined the association between absolute O2 pulse, O2 pulse slope and SV during exercise. These participants were part of a study analysing the effects of inspiratory muscle training, as previously described.16 Cohort A was participants identified through the cardiology database at The Children’s Hospital at Westmead (CHW) in Sydney, Australia. Only participants with a non-fenestrated extracardiac conduit aged 12–20 years were included.

    2. In the second cohort (cohort B—131 subjects with 131 CPETs and transthoracic echocardiograms (TTE)), we examined the association between clinical characteristics and O2 pulse parameters. These participants with a Fontan circulation were identified through the Australian and New Zealand Fontan Registry (ANZFR) and were part of the ANZFR Functional Outcomes after Fontan study conducted across Sydney, Melbourne and Auckland. Inclusion criteria for this study were age ≥13 years and ≥5 years since Fontan completion.

    Figure 1
    Figure 1

    Study participants. AT, anaerobic threshold; CPET, cardiopulmonary exercise testing; ExCMR, exercise cardiac magnetic resonance; n, number of subjects; N, number of tests; TTE, transthoracic echocardiogram.

    Exclusion criteria for both cohorts were those with severe heart failure, a history of significant exercise-induced arrhythmia, severe systemic outflow tract obstruction or severe systemic hypertension at rest, or significant cognitive impairment or intellectual disability. Clinical data for Fontan participants were retrospectively collected from the local cardiology database at CHW (cohort A) and the ANZFR REDCap database (cohort B, hosted by the Murdoch Children’s Research Institute).

    Cohort A subjects underwent CPET at CHW. A subset of these patients underwent exCMR, also performed at CHW.16 Cohort B subjects underwent CPET and TTE at one of four sites—Sydney (CHW and The Royal Prince Alfred Hospital, RPAH), Melbourne (The Royal Children’s Hospital) and Auckland (Starship Children’s Hospital).

    To compare O2 pulse parameters between Fontan subjects and healthy controls, data from healthy controls were obtained through the exercise labs at CHW, RPAH and the Women’s and Children’s Hospital in Adelaide, Australia (n=56). These subjects had no underlying cardiac, respiratory or neurological conditions and were undergoing exercise testing for non-specific symptoms.

    Cardiopulmonary exercise testing

    CPET was performed in all participants, in a standardised fashion on an upright cycle ergometer using a progressive ramp protocol, aiming to achieve peak oxygen consumption (VO2) within 7–10 min. Cohort A underwent CPET at baseline and at 6 weeks after inspiratory muscle training (n=40). HR, blood pressure and oxygen saturations were recorded from rest to recovery. Breath-by-breath VO2, carbon dioxide consumption (VCO2) and minute ventilation (VE) were measured. Anaerobic threshold (AT) was calculated using a combination of the V-slope, ventilatory equivalents and respiratory exchange ratio methods.

    O2 pulse was calculated throughout testing, from the start of exercise until the beginning of recovery. Absolute O2 pulse was determined at AT (O2pulseAT) and at peak exercise (O2pulsePEAK). O2 pulse against time curves were reviewed and the curves were determined to have an overall linear pattern, without clear inflection points at consistent time points. Due to this pattern, lines of best fit for O2 pulse against exercise time up to AT (O2pulseslopeAT) and peak (O2pulseslopePEAK) were determined by regression (GraphPad Prism V.9), and the slope of these regression lines were taken as the O2 pulse slope (see figure 2 as representative). Lines of best fit were visually checked by two independent observers (KL and JA) and poorly fitting lines were excluded by agreement (five slopes from cohort A and five slopes from cohort B were thus excluded). No slopes from the control cohort were excluded. For analysis, indexing of O2 pulse metrics to body surface area was not undertaken given that indexing of aortic flow was also not undertaken.

    Figure 2
    Figure 2

    O2 pulse. AT, anaerobic threshold.

    Spirometry

    Spirometry was performed in all participants using standardised techniques.17 Forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1) were measured, and per cent predicted FVC and FEV1 were determined.18

    ExCMR imaging

    ExCMR was performed (1.5T, Phillips Intera, Best, The Netherlands) at baseline (n=14) and then 6 weeks after inspiratory muscle training (n=12).16 Exercise in the MRI scanner was undertaken using an MRI compatible stepper (Ergospect, Innsbruck, Austria). Testing was performed on the same day as the cardiopulmonary exercise test. The initial workload was set to 30W, and increased by 20W every 3 min until exhaustion. Flow and cine imaging was acquired from 50% of the participants’ maximum workload based on the prior CPET, and at every stage thereafter until fatigue. Resting and exercise non-gated real time phase contrast flow (200 consecutive dynamics, dynamic scan time 75 ms, corresponding to approximately 15 s of flow data) was measured. Ascending aortic flow was measured at rest (Aortic flowREST) and at the final stage prior to exhaustion (Aortic flowPEAK), as a measure of SV. Typical scan parameters for balanced steady-state free-precession cine imaging have been described previously.16 Ventricular volumes were determined by manual contouring of the endocardial border of each short axis slice, at end-diastole (EDV) and end-systole volume (ESV). Ejection fraction was calculated (EF=(EDV-ESV)/EDV×100%). To study the association between SV and O2 pulse metrics, all ExCMR studies and their corresponding CPET (n=26) were analysed.

    Echocardiography

    Participants in cohort B had TTEs performed and the following were obtained: anatomy, ventricular dominance, atrioventricular (AV)-valve regurgitation (none-trivial, or mild or more) and global systolic dysfunction as a qualitative measurement (normal or impaired).

    Statistical analyses

    Statistical analyses were performed using GraphPad Prism V.9. Non-parametric and parametric data are presented as median (range) or mean±SD, respectively. Categorical and continuous data were compared between healthy and Fontan groups using χ2 tests, t-tests or Mann-Whitney U tests, as appropriate. Correlations between clinical Fontan and O2 pulse parameters were assessed using Pearson or Spearman correlation and multiple linear regression models. A p<0.05 was considered statistically significant.

    Results

    The baseline characteristics of cohort A and cohort B are shown in table 1. Cohort B included a wider age range, with an older mean age than cohort A (23.0 vs 15.8 years). Due to the inclusion criteria of cohort A, more subjects in cohort B were fenestrated at the time of Fontan completion and had non-extracardiac conduits. Other baseline characteristics were similar between the two Fontan groups. Characteristics of the control subjects were: 33 (59%) males, age 29.5±12.0 years, height 169.8±11.8 cm, weight 77.5±22.2 kg and body mass index 22.7±6.0. Resting and peak parameters obtained during CPET and exCMR are compared in online supplemental table 1. Results from the CPET have previously been reported.16 19 Peak workload between CPET and exCMR positively correlated (r=0.64, p<0.001).

    View this table:
    Table 1

    Anthropometrics and clinical characteristics of Fontan subjects (cohorts A and B)

    There was no significant difference in O2pulsePEAK, O2pulseAT, O2pulseslopePEAK or O2pulseslopeAT, between cohort A and B (figure 3). Both Fontan cohorts had significantly lower peak VO2, O2pulsePEAK, O2pulseAT and O2pulseslopePEAK compared with healthy controls. O2pulseslopeAT was significantly different between cohort A and healthy controls, but not between cohort B and healthy controls (table 2, figure 3).

    Figure 3
    Figure 3

    O2 pulse parameters. AT, anaerobic threshold.

    View this table:
    Table 2

    O2 pulse parameters

    In cohort A, aortic flowPEAK was moderately and significantly associated with O2pulseslopePEAK (r=0.47, p=0.02) but was not significantly associated with O2pulseslopeAT (r=0.37, p=0.09). Neither O2pulsePEAK nor O2pulseAT correlated with aortic flowPEAK (r=−0.05, p=0.82; r=0.20, p=0.33, respectively). There was a weak negative association between EF measured at peak exercise on exCMR and O2 pulse at peak and rest (r=−0.40, p=0.03; r=−0.53, p<0.01, respectively). There were no significant associations between EF and other O2 pulse parameters.

    In cohort B, neither resting nor peak oxygen saturation were correlated with any of the O2 pulse parameters (data not shown). O2pulseslopePEAK correlated with O2pulsePEAK (r=0.56, p<0.01) and O2pulseslopeAT with O2pulseAT (p<0.01, r=0.44). O2pulsePEAK and O2pulseAT were negatively associated with age of Fontan completion (r=−0.19, p=0.03;r=−0.20, p=0.03, respectively). O2pulseslopeAT was associated with severity of AV-valve regurgitation (U=847, p=0.03) with a lower slope in those with at least mild regurgitation. However, AV-valve regurgitation was not associated with O2pulseslopePEAK. O2pulseslopePEAK and O2pulseslopeAT were not significantly associated with other clinical variables including ventricular morphology or function, Fontan type, age of Fontan completion, presence of fenestration or pacemaker, presence of permanent pacemaker or use of HR-limiting medications (online supplemental table 2). Baseline FVC %predicted but not FEV1 was weakly associated with O2pulsePEAK O2pulseslopePEAK (r=0.2, p=0.03) and O2pulseslopeAT (r=0.21, p=0.03).

    Discussion

    We have demonstrated a positive association between O2 pulse slope to peak exercise and SV, in patients with a Fontan circulation. We have also confirmed the lack of association between peak O2 pulse and SV, as previously demonstrated by other authors.14 Our data suggest that O2 pulse slope, which incorporates O2 pulse kinetics across exercise, may be a better surrogate marker than absolute peak O2 pulse of maximal SV during exercise in Fontan patients.

    SV and the a-vO2 difference

    O2 pulse is determined by SV and oxygen extraction (a-vO2 difference). In untrained healthy subjects, SV increases during exercise but then plateaus at a submaximal load.20 The a-vO2 difference, however, increases as a linear function during exercise in healthy subjects, and is the main determinant of O2 pulse from mid-exercise.10 SV and a-vO2 difference responses across exercise in patients with a Fontan circulation appear to be more heterogeneous.

    SV has been shown to increase throughout exercise in some Fontan patients but plateau or decrease in others at maximum exertion.14 21–24 This variable SV response may relate to differences in underlying patient characteristics but also to differences in the way SV is measured across different studies. Although submaximal and maximal HR is lower in Fontan patients than healthy controls,6 24 25 the slope of the response of HR against workload or VO2 appears to be higher or equivalent.6 24 The exercise chronotropic response of patients with a Fontan circulation may thus be adaptive to preload insufficiency in order to maintain ventricular filling and cardiac output. In keeping with these data, we did not find a difference in the O2 pulse slope up to AT between Fontan patients and controls.

    In a small study of 10 Fontan subjects before and after a single dose of sildenafil, Van De Bruaene et al showed decreasing SV (measured by ExCMR) and increasing a-vO2 difference (measured from direct arterial and venous blood sampling) from rest to peak exercise.23 In a study of 15 children with a Fontan circulation, Strömvall Larsson and Eriksson showed increasing a-vO2 difference across exercise but with considerable variability in the difference at peak exercise (median 16.8, range 10.5–21.5 mL/100 mL).22 Rosenthal et al demonstrated higher a-vO2 difference in 43 children with a Fontan circulation compared with healthy controls at rest and across all stages of exercise.26

    The impact of chronic cyanosis on a-vO2 has been poorly studied. It is possible that cyanosis, related to the either the presence of a fenestration or systemic venous collateral, results in a reduced ability to augment oxygen extraction at peak exercise or impaired microcirculatory function. We found no association between O2 pulse parameters and either the presence of a fenestration or resting or peak oxygen saturation. This is in keeping with a study by Loomba et al showing similar exercise arterial-venous saturation difference (utilising regional near infrared spectroscopy) in fenestrated versus non-fenestrated Fontan patients27 and a study by Strieder et al showing similar tissue oxygenation during exercise in cyanotic versus repaired acyanotic CHD.28 We speculate that a more heterogeneous a-vO2 difference during exercise in patients with a Fontan circulation may explain the poor association of peak O2 pulse with SV. However, this would need to be examined in a future study where exercise SV, O2 pulse and a-vO2 difference are directly measured.

    Association between O2 pulse slope and clinical variables

    In our exploratory study, we found no association between clinical variables and O2pulseslopePEAK or O2pulseslopeAT, apart from a weakly positive association with baseline FVC %predicted. There was no association with other spirometry parameters.

    Fontan subjects have been shown to have abnormal spirometry, with an association between FVC and peak VO2.19 29 Its association with O2 pulse slope is beyond the scope of this study, however, may reflect a ventilation driven inability to augment pulmonary blood flow, and therefore, SV.

    O2 pulse and long-term outcomes

    Neither O2 pulse nor its change over serial testing have been shown to predict long-term adverse Fontan outcomes.30 We speculate that, in part, this relates to its poor correlation with SV in Fontan patients. It would be of interest to investigate the association between O2 pulse slope and its change and long-term Fontan outcomes.

    Implications of study findings and study limitations

    In a study of 411 Fontan subjects (age 12.4±3.2 years, 166 achieving a maximal exercise test) Paridon et al found, as expected, that per cent predicted peak O2 pulse was strongly associated with per cent predicted peak VO2 and moderately with per cent predicted VO2 at AT.3 Based on the strength of these associations, the authors inferred that SV limitation was solely responsible for the variation in aerobic performance. However, our data suggest caution in using peak O2 pulse as a surrogate marker for SV in Fontan patients. We speculate that this may relate to a greater variability in the a-vO2 difference at peak compared with submaximal exercise.

    As this was a preliminary study, our study cohorts were small, and we did not have exCMR data available for cohort B. However, even based on our small cohort A, we were still able to demonstrate a moderately significant association between O2 pulse slope to peak exercise and peak SV.

    Our exCMR protocol was performed using recumbent exercise, likely producing submaximal exercise testing; compared with our upright cycle ergometer CPET. The use of serial gas measurements and CMR-augmented CPET, including continuous oxygen saturation monitoring, would have allowed simultaneous assessment of gas exchange, and a-vO2 during exercise.

    Our healthy controls were retrospectively obtained from subjects previously undergoing CPET, and therefore, we did not have a prospectively matched cohort. However, given the older age of the control subjects, we are more likely to have underestimated the significance of the difference between our Fontan and control cohorts.

    Given our relatively small sample size and short-term follow-up, we were unable to examine whether O2 pulse slope predicted adverse long-term Fontan outcomes. In our exploratory analysis of cohort B, adjustments for multiple comparisons were not performed, increasing the risk of type I error. Further larger studies would be of interest to analyse the association between O2 pulse parameters and clinical variables.

    Conclusion

    Peak O2 pulse slope may be more reflective of peak SV in the Fontan population than a single peak O2 pulse value, taking into account changes in a-vO2 during exercise. The O2 pulse slope may be a useful submaximal marker of SV.

    Data availability statement

    All data relevant to the study are included in the article or uploaded as online supplemental information.

    Ethics statements

    Patient consent for publication

    Ethics approval

    This study involves human participants and the study was approved by the Sydney Children’s Hospitals Network Human Research Ethics Committee. Reference numbers: HREC/15/SCHN/249 and HREC/14/SCHN/278. Participants gave informed consent to participate in the study before taking part.

    Acknowledgments

    This study is based on one of the authors’ thesis—Laohachai, K (2023). Cardiopulmonary Interactions and Exercise Capacity in Patients with a Fontan Circulation. PhD thesis, University of Sydney, Sydney Australia.

    References

    1. ↵
      1. Egbe AC,
      2. Driscoll DJ,
      3. Khan AR, et al
      . Cardiopulmonary exercise test in adults with prior Fontan operation: the prognostic value of serial testing. Int J Cardiol 2017;235:6–10. doi:10.1016/j.ijcard.2017.02.140
      OpenUrlPubMed
    2. ↵
      1. Diller G-P,
      2. Giardini A,
      3. Dimopoulos K, et al
      . Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients. Eur Heart J 2010;31:3073–83. doi:10.1093/eurheartj/ehq356
      OpenUrlCrossRefPubMedWeb of Science
    3. ↵
      1. Paridon SM,
      2. Mitchell PD,
      3. Colan SD, et al
      . A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation. J Am Coll Cardiol 2008;52:99–107. doi:10.1016/j.jacc.2008.02.081
      OpenUrlFREE Full Text
    4. ↵
      1. Terol Espinosa de Los Monteros C,
      2. Harteveld LM,
      3. Kuipers IM, et al
      . Prognostic value of maximal and submaximal exercise performance in Fontan patients < 15 years of age. Am J Cardiol 2021;154:92–8. doi:10.1016/j.amjcard.2021.05.049
      OpenUrl
    5. ↵
      1. Chen C-A,
      2. Chen S-Y,
      3. Chiu H-H, et al
      . Prognostic value of submaximal exercise data for cardiac morbidity in Fontan patients. Med Sci Sports Exerc 2014;46:10–5. doi:10.1249/MSS.0b013e31829f8326
      OpenUrlCrossRefPubMed
    6. ↵
      1. Hedlund ER,
      2. Söderström L,
      3. Lundell B
      . Appropriate heart rate during exercise in Fontan patients. Cardiol Young 2020;30:674–80. doi:10.1017/S1047951120000761
      OpenUrl
    7. ↵
      1. Mezzani A
      . Cardiopulmonary exercise testing: basics of methodology and measurements. Ann Am Thorac Soc 2017;14:S3–11. doi:10.1513/AnnalsATS.201612-997FR
      OpenUrlCrossRefPubMed
    8. ↵
      1. Unnithan V,
      2. Rowland TW
      . Use of oxygen pulse in predicting Doppler-derived maximal stroke volume in adolescents. Pediatr Exerc Sci 2015;27:412–8. doi:10.1123/pes.2014-0215
      OpenUrl
    9. ↵
      1. Crisafulli A,
      2. Piras F,
      3. Chiappori P, et al
      . Estimating stroke volume from oxygen pulse during exercise. Physiol Meas 2007;28:1201–12. doi:10.1088/0967-3334/28/10/006
      OpenUrlCrossRefPubMedWeb of Science
    10. ↵
      1. Stringer WW,
      2. Hansen JE,
      3. Wasserman K
      . Cardiac output estimated noninvasively from oxygen uptake during exercise. J Appl Physio 1997;82:908–12. doi:10.1152/jappl.1997.82.3.908
      OpenUrlPubMedWeb of Science
    11. ↵
      1. Cordina R,
      2. O’Meagher S,
      3. Gould H, et al
      . Skeletal muscle abnormalities and exercise capacity in adults with a Fontan circulation. Heart 2013;99:1530–4. doi:10.1136/heartjnl-2013-304249
      OpenUrlAbstract/FREE Full Text
    12. ↵
      1. Brassard P,
      2. Poirier P,
      3. Martin J, et al
      . Impact of exercise training on muscle function and ergoreflex in Fontan patients: a pilot study. Int J Cardiol 2006;107:85–94. doi:10.1016/j.ijcard.2005.02.038
      OpenUrlCrossRefPubMed
    13. ↵
      1. Wittekind S,
      2. Mays W,
      3. Gerdes Y, et al
      . A novel mechanism for improved exercise performance in pediatric Fontan patients after cardiac rehabilitation. Pediatr Cardiol 2018;39:1023–30. doi:10.1007/s00246-018-1854-3
      OpenUrl
    14. ↵
      1. Legendre A,
      2. Guillot A,
      3. Ladouceur M, et al
      . Usefulness of stroke volume monitoring during upright ramp incremental cycle exercise in young patients with Fontan circulation. Int J Cardiol 2017;227:625–30. doi:10.1016/j.ijcard.2016.10.087
      OpenUrlPubMed
    15. ↵
      1. Bansal M,
      2. Fiutem JJ,
      3. Hill JA, et al
      . Oxygen pulse Kinetics in Fontan patients during treadmill ramp protocol cardiopulmonary exercise testing. Pediatr Cardiol 2012;33:1301–6. doi:10.1007/s00246-012-0308-6
      OpenUrlPubMed
    16. ↵
      1. Laohachai K,
      2. Winlaw D,
      3. Selvadurai H, et al
      . Inspiratory muscle training is associated with improved Inspiratory muscle strength, resting cardiac output, and the ventilatory efficiency of exercise in patients with a Fontan circulation. J Am Heart Assoc 2017;6:e005750. doi:10.1161/JAHA.117.005750
    17. ↵
      1. Graham BL,
      2. Steenbruggen I,
      3. Miller MR, et al
      . Standardization of spirometry 2019 update. an official American Thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med 2019;200:e70–88. doi:10.1164/rccm.201908-1590ST
      OpenUrlCrossRefPubMed
    18. ↵
      1. Wang X,
      2. Dockery DW,
      3. Wypij D, et al
      . Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993;15:75–88. doi:10.1002/ppul.1950150204
      OpenUrlCrossRefPubMedWeb of Science
    19. ↵
      1. Laohachai K,
      2. Badal T,
      3. Thamrin C, et al
      . Older age at Fontan completion is associated with reduced lung volumes and increased lung reactance. Int J Cardiol 2022;364:38–43. doi:10.1016/j.ijcard.2022.06.037
      OpenUrl
    20. ↵
      1. Stringer WW,
      2. Whipp BJ,
      3. Wasserman K, et al
      . Non-linear cardiac output dynamics during ramp-incremental cycle ergometry. Eur J Appl Physiol 2005;93:634–9. doi:10.1007/s00421-004-1258-3
      OpenUrlCrossRefPubMedWeb of Science
    21. ↵
      1. Driscoll DJ,
      2. Danielson GK,
      3. Puga FJ, et al
      . Exercise tolerance and cardiorespiratory response to exercise after the Fontan operation for Tricuspid Atresia or functional single ventricle. J Am Coll Cardiol 1986;7:1087–94. doi:10.1016/s0735-1097(86)80227-3
      OpenUrlFREE Full Text
    22. ↵
      1. Strömvall Larsson E,
      2. Eriksson BO
      . Haemodynamic adaptation during exercise in Fontan patients at a long-term follow-up. Scand Cardiovasc J 2003;37:107–12. doi:10.1080/4017430310001221
      OpenUrlPubMed
    23. ↵
      1. Van De Bruaene A,
      2. La Gerche A,
      3. Claessen G, et al
      . Sildenafil improves exercise hemodynamics in Fontan patients. Circ Cardiovasc Imaging 2014;7:265–73. doi:10.1161/CIRCIMAGING.113.001243
      OpenUrlAbstract/FREE Full Text
    24. ↵
      1. Claessen G,
      2. La Gerche A,
      3. Van De Bruaene A, et al
      . Heart rate reserve in Fontan patients: chronotropic incompetence or hemodynamic limitation J Am Heart Assoc 2019;8:e012008. doi:10.1161/JAHA.119.012008
    25. ↵
      1. Diller G-P,
      2. Okonko DO,
      3. Uebing A, et al
      . Impaired heart rate response to exercise in adult patients with a systemic right ventricle or univentricular circulation: prevalence, relation to exercise, and potential therapeutic implications. Int J Cardiol 2009;134:59–66. doi:10.1016/j.ijcard.2008.01.032
      OpenUrlCrossRefPubMed
    26. ↵
      1. Rosenthal M,
      2. Bush A,
      3. Deanfield J, et al
      . Comparison of cardiopulmonary adaptation during exercise in children after the atriopulmonary and total cavopulmonary connection Fontan procedures. Circulation 1995;91:372–8. doi:10.1161/01.cir.91.2.372
      OpenUrlAbstract/FREE Full Text
    27. ↵
      1. Loomba RS,
      2. Danduran ME,
      3. Dixon JE, et al
      . Effect of Fontan fenestration on regional venous oxygen saturation during exercise: further insights into Fontan fenestration closure. Pediatr Cardiol 2014;35:514–20. doi:10.1007/s00246-013-0817-y
      OpenUrl
    28. ↵
      1. Strieder DJ,
      2. Mesko ZG,
      3. Zaver AG, et al
      . Exercise tolerance in chronic hypoxemia due to right-to-left shunt. J Appl Physiol 1973;34:853–8. doi:10.1152/jappl.1973.34.6.853
      OpenUrlPubMedWeb of Science
    29. ↵
      1. Opotowsky AR,
      2. Landzberg MJ,
      3. Earing MG, et al
      . Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity. Am J Physiol Heart Circ Physiol 2014;307:H110–7. doi:10.1152/ajpheart.00184.2014
      OpenUrlCrossRefPubMed
    30. ↵
      1. Udholm S,
      2. Aldweib N,
      3. Hjortdal VE, et al
      . Prognostic power of cardiopulmonary exercise testing in Fontan patients: a systematic review. Open Heart 2018;5:e000812. doi:10.1136/openhrt-2018-000812

    Supplementary materials

    • Supplementary Data

      This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Footnotes

    • Contributors KL and JA designed the study, collected the data, drafted the manuscript and were responsible for analysis and interpretation of results. All authors provided substantial contribution to reviewing the results, providing critical revisions and approving the final version of the manuscript. JA is responsible for the overall content as the guarantor.

    • Funding The ANZFR Functional Outcomes after Fontan study was funded by a National Health and Medical Research Council Project grant (APP1065794).

    • Competing interests None declared.

    • Patient and public involvement Patients and the public were not directly involved in the study design or analyses. This study was endorsed by the ANZFR steering committee, which include patients and their representatives.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Author note All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.

    • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.